Clik here to view.
Kubota Vision Announces Agreement with AUROLAB for Development,...
SEATTLE Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo...
View ArticleClik here to view.
Cellusion Receives U.S. FDA Orphan Drug Designation for CLS001
TOKYO Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusion”), a deep tech start-up developing a novel cell therapy, announced that the U.S. Food and Drug Administration (“FDA”) has granted Orphan...
View ArticleClik here to view.
Fabrinet Publishes 2023 Sustainability Report
BANGKOK, Thailand Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment...
View ArticleClik here to view.
Located in Seoul, Korea, Topcon Korea Medical Co., Ltd. (TKM) Was Established...
SEOUL, South Korea Topcon Corporation (HQ: Itabashi-ku, Tokyo; President: Takashi Eto) (henceforth Topcon Healthcare) has established Topcon Korea Medical Co., Ltd. (HQ: Seoul, South Korea,...
View ArticleClik here to view.
位于韩国首尔的Topcon Korea Medical Co., Ltd. (TKM) 于2023年成立并正式启动
韩国首尔 (美国商业资讯)– Topcon Corporation (总部：东京都板桥区；总裁：Takashi Eto) (以下称“Topcon Healthcare”) 在韩国成立Topcon Korea Medical Co. (总部：韩国首尔，总裁：Artur Chu) (以下称“TKM”) ，以加强并扩大其在韩国的眼科业务。...
View ArticleClik here to view.
韓国ソウルに株式会社トプコンコリアメディカル（TKM）設立、2023年に正式始動
韓国ソウル （ビジネスワイヤ） — 株式会社トプコン（本社：東京都板橋区、代表取締役社長：江藤隆志）（以下トプコン・ヘルスケア）が韓国でアイケア事業を強化・拡大するため、株式会社トプコンコリアメディカル（本社：韓国ソウル、代表取締役社長：Artur Chu）（以下TKM）を設立しました。...
View ArticleClik here to view.
EyeBio Announces Positive Visual, Anatomic and Safety Data from...
NEW YORK & LONDON Eyebiotech Limited (“EyeBio” or “the Company”) announced today the presentation of Week 12 data from its first-in-human Phase 1b/2a AMARONE trial of Restoret in patients with...
View ArticleClik here to view.
New Swiss Made Features for Cataract Surgery Lens Selection
NEUCHATEL, Switzerland The company Swiss Advanced Vision (SAV-IOL SA) has announced the launch of New Features for its Toric Calculator improving the overall calculation experience. For the...
View ArticleClik here to view.
白内障手术镜片选择的新瑞士制造特性
瑞士, 纳沙泰尔 (美国商业资讯)– Swiss Advanced Vision （SAV-IOL SA）宣布推出其扭曲计算器的新功能，以改善整体计算体验。眼科医生首次能够利用基于患者光学参数的网络配置器来帮助确定最佳的切口位置，以最小化手术后残留的散光。而且，适用于所有类型的镜片。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Clik here to view.
STAAR Surgical to Participate in Two Upcoming Investor Conferences
LAKE FOREST, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and...
View ArticleClik here to view.
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon...
BENGALURU, India Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon® Family of intraocular lenses (IOLs) in...
View ArticleClik here to view.
Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical...
SEATTLE & CAMBRIDGE, Mass. & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has dosed the...
View ArticleClik here to view.
Aurion Biotech to Present Clinical Data at the 2024 American Society of...
SEATTLE, CAMBRIDGE, Mass. & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced several presentations...
View ArticleClik here to view.
拨康视云（Cloudbreak Pharma） 最新调查结果凸显眼疾负担，彰顯非手术治疗选项对于被低估和未充分治疗的翼状胬肉眼疾的重要性
加州尔湾 (美国商业资讯)– 拨康视云是一家临床阶段的生物技术公司，致力于开发治疗常见但治療方案甚少的眼科疾病的药物。該公司在波士顿举行的年度ASCRS会议上分享了一项由公司支持的调查数据，该调查彰顯了翼状胬肉的患者负担。翼状胬肉是一种眼部疾病，通常被称为“冲浪者眼”，可能是暴露于高水平紫外线辐射環境而引起的。1...
View ArticleClik here to view.
拨康视云（Cloudbreak Pharma） 最新调查结果凸显眼疾负担，彰显非手术治疗选项对于被低估和未充分治疗的翼状胬肉眼疾的重要性
加州尔湾 (美国商业资讯)– 拨康视云是一家临床阶段的生物技术公司，致力于开发治疗常见但治疗方案甚少的眼科疾病的药物。该公司在波士顿举行的年度ASCRS会议上分享了一项由公司支持的调查数据，该调查彰显了翼状胬肉的患者负担。翼状胬肉是一种眼部疾病，通常被称为“冲浪者眼”，可能是暴露于高水平紫外线辐射环境而引起的。1...
View ArticleClik here to view.
Aurion Biotech Announces Completion of Enrollment in Phase 1 / 2 Clinical Trial
SEATTLE & CAMBRIDGE, Mass. & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has completed...
View ArticleClik here to view.
Ora and Singapore Eye Research Institute Unveil Groundbreaking Partnership to...
BOSTON & SINGAPORE Ora, Inc., the foremost global ophthalmology contract research organization (CRO), today announced a strategic, exclusive partnership with the Singapore Eye Research Institute...
View ArticleClik here to view.
Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation...
GUILFORD, Conn. & SHANGHAI Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral,...
View ArticleClik here to view.
LambdaVision Announces First Closing of Seed Round to Advance Artificial...
FARMINGTON, Conn. LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, announced it secured...
View Article